When aneurysmal subarachnoid hemorrhage (aSAH) presents with seizures, managing seizure activity through the perioperative period becomes a distinct clinical priority requiring a protocol-driven approach.
Aneurysmal subarachnoid hemorrhage presenting with seizures. This scenario calls for targeted perioperative seizure management — the clinical goal is control of seizures during the perioperative period to reduce seizure-related complications.
A short-course antiseizure strategy is used in this setting — but agent selection is critical, as specific medications are excluded from this protocol due to their association with excess morbidity and mortality.
DOI: 10.1161/str.0000000000000436
In patients with aSAH who present with seizures, treatment with antiseizure medications for ≤7 days is reasonable to reduce seizure-related complications in the perioperative period.
In patients with aSAH, phenytoin for seizure prevention and/or antiseizure prophylaxis is associated with excess morbidity and mortality.
View source ↗